We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000538:SZSEYunnan Baiyao Group Co.,Ltd Analysis

Data as of 2026-09-11 - not real-time

CN¥50.45

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At ¥50.45, Yunnan Baiyao Group Co.,Ltd shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have lost 4.6%. Relative strength is 49.8 — neutral — and the MACD signal is bullish. Price has been bracketed by support at ¥49.03 and resistance at ¥51.24.
On valuation the read is undervalued — earnings multiple of 17.3 versus a 29.6 sector average, below the peer group. Consensus targets land 34.9% above where the shares trade now. The 3.14% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 11.9%, a beta of 0.06 and a maximum drawdown of 21.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.

Top Market Events

Yunnan Baiyao Group maintains a strong position in China's tartar control toothpaste segment, estimaYunnan Baiyao Group shares trade around CNY 50 on the Shenzhen Stock Exchange, putting the tradition

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 53.35
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 17.3 versus sector average of 29.6
  • Trading below the 200-day average of 53.35

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 17.3 versus sector average of 29.6
  • Analyst targets imply +34.9% versus the current price
  • Revenue contracting at -1.3%

Key Metrics & Analysis

Financial Health

Revenue Growth-1.30%
Profit Margin12.49%
P/E Ratio17.3
ROE12.86%
ROA5.51%
Debt/Equity0.79
P/B Ratio2.2
Op. Cash FlowCN¥4.7B
Free Cash FlowCN¥3.2B
Industry P/E29.6

Technical Analysis

TrendBearish
RSI49.8
SupportCN¥49.03
ResistanceCN¥51.24
MA 20CN¥50.23
MA 50CN¥50.59
MA 200CN¥53.35
MACDBullish
VolumeStable
Fear & Greed Index89.57

Valuation

Fair ValueCN¥30.31
Target PriceCN¥68.06
Upside/Downside34.90%
GradeUndervalued
TypeValue
Dividend Yield3.14%

Risk Assessment

Beta0.06
Volatility11.86%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.